Get the Stockscreener App
2.43
0.00%
0.00
Pre-market:
2.28
-0.15
-6.17%
Psyence Biomedical Ltd Stock (PBM) Forecast
The Psyence Biomedical Ltd (PBM) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.6305, representing a +49.40% increase from the current price of $2.43. The highest analyst price target is $3.6007, and the lowest is $3.6603.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PBM Price Target
Average 5.5902
(+130.05% Upside)
Is Psyence Biomedical Ltd (PBM) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 42.96 | Neutral |
| STOCH(9,6) | 45.00 | Neutral |
| STOCHRSI(14) | 46.40 | Neutral |
| MACD(12,26) | -0.1382 | Buy |
| ADX(14) | 24.67 | Neutral |
| William %R | -53.12 | Neutral |
| CCI(14) | -96.91 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.459
Sell
|
2.4567
Sell
|
| MA20 |
2.5085
Sell
|
2.5161
Sell
|
| MA50 |
2.5596
Sell
|
3.6024
Sell
|
| MA100 |
6.7853
Sell
|
7.7049
Sell
|
| MA200 |
16.83
Sell
|
20.56
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, PBM could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 10 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on PBM, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 42.96 indicates that PBM is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 45 indicates that PBM is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 46.4 indicates that PBM is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 24.67 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -96.91 indicates that PBM is still oversold but not to an extreme extent.
Long-term PBM price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Psyence Biomedical Ltd financial reports and earnings history, Psyence Biomedical Ltd (PBM) stock could reach $15.23 by 2030, $42.23 by 2040 and $69.24 by 2050. See the projected annual prices until 2050 of the Psyence Biomedical Ltd stock below:
- Psyence Biomedical Ltd (PBM) is expected to reach an average price of $33.35 in 2035, with a high prediction of $33.46 and a low estimate of $18.29. This indicates an $1,272% rise from the last recorded price of $2.43.
- Psyence Biomedical Ltd (PBM) stock is projected to chart a bullish course in 2040, with an average price target of $37.42, representing an $1,440% surge from its current level. The forecast ranges from a conservative $37.46 to a sky-high $42.23.
- Our analysts predict Psyence Biomedical Ltd (PBM) to jump 2,635% by 2045, soaring from $36.22 to an average price of $66.46, potentially reaching $66.22. While $36.22 is the low estimate, the potential upside is significant.
- Psyence Biomedical Ltd (PBM) stock is expected to climb by 2050, reaching an average of $61.70, a $2,439% jump from its current level. However, a wide range of estimates exists, with high and low targets of $69.24 and $61.74, respectively, highlighting the market's uncertainty.
Psyence Biomedical Ltd Stock (PBM) Year by Year Forecast
Psyence Biomedical Ltd Stock (PBM) Price Forecast for 2026
The predicted value for Psyence Biomedical Ltd (PBM) in 2026 is set at an average of $4.7685. Estimates vary from a peak of $7.3295 to a trough of $2.2075, indicating an +96.24% surge from the present price of $2.43.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2026 | $3.6534 | $3.6603 | $3.6007 | +50.35% |
| May, 2026 | $3.1409 | $2.826 | $3.4558 | +29.25% |
| June, 2026 | $6.5812 | $6.00 | $5.8434 | +170.83% |
| July, 2026 | $4.1892 | $5.719 | $6.3046 | +72.39% |
| August, 2026 | $4.4388 | $4.4736 | $4.4381 | +82.66% |
| September, 2026 | $3.8147 | $3.4445 | $4.1849 | +56.98% |
| October, 2026 | $7.6374 | $7.15 | $6.8996 | +214.30% |
| November, 2026 | $6.8772 | $6.9162 | $7.3295 | +183.01% |
| December, 2026 | $5.2136 | $5.2484 | $5.2754 | +114.55% |
Psyence Biomedical Ltd Stock (PBM) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Psyence Biomedical Ltd (PBM) is $7.2337, with a high forecast of $10.40 and a low forecast of $4.063. This indicates an +197.68% increase from the last price of $2.43.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $4.2987 | $4.3315 | $4.9285 | +76.90% |
| February, 2027 | $8.3372 | $4.063 | $7.8372 | +243.10% |
| March, 2027 | $7.8083 | $7.8473 | $8.3545 | +221.33% |
| April, 2027 | $6.1148 | $6.1948 | $6.1128 | +151.64% |
| May, 2027 | $5.2704 | $5.4593 | $5.7934 | +116.89% |
| June, 2027 | $9.4247 | $4.6815 | $8.9247 | +287.85% |
| July, 2027 | $9.0741 | $9.0911 | $9.3794 | +273.42% |
| August, 2027 | $7.2735 | $7.3135 | $8.7115 | +199.32% |
| September, 2027 | $5.9514 | $6.1403 | $6.8209 | +144.91% |
| October, 2027 | $10.53 | $5.30 | $9.9662 | +333.17% |
| November, 2027 | $10.39 | $10.42 | $10.40 | +327.41% |
| December, 2027 | $8.1109 | $8.1509 | $9.9765 | +233.78% |
Psyence Biomedical Ltd Stock (PBM) Price Forecast for 2028
In 2028, Psyence Biomedical Ltd (PBM) is projected to reach an average price of $9.6988, with a high projection of $13.48 and a low estimate of $5.9185. This indicates an +299.13% rise from the last price of $2.43.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $7.1566 | $7.2041 | $7.627 | +194.51% |
| February, 2028 | $11.45 | $5.9185 | $9.87 | +371.19% |
| March, 2028 | $11.38 | $11.41 | $11.43 | +368.30% |
| April, 2028 | $9.1334 | $9.4634 | $10.94 | +275.86% |
| May, 2028 | $7.8689 | $7.9164 | $8.6248 | +223.82% |
| June, 2028 | $12.60 | $6.537 | $11.02 | +418.52% |
| July, 2028 | $12.66 | $12.69 | $12.45 | +420.78% |
| August, 2028 | $10.00 | $10.33 | $12.22 | +311.61% |
| September, 2028 | $8.8584 | $8.8653 | $9.4622 | +264.54% |
| October, 2028 | $7.7986 | $7.1555 | $8.4418 | +220.93% |
| November, 2028 | $13.68 | $13.72 | $13.48 | +462.96% |
| December, 2028 | $10.49 | $12.02 | $13.21 | +331.62% |
Psyence Biomedical Ltd Stock (PBM) Price Forecast for 2029
The 2029 price forecast for Psyence Biomedical Ltd Stock (PBM) is $12.23 on average, with a high prediction of $16.68 and a low estimate of $7.774. This represents an +403.14% increase from the previous price of $2.43.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $9.6019 | $9.6088 | $10.30 | +295.14% |
| February, 2029 | $8.464 | $7.774 | $9.1541 | +248.31% |
| March, 2029 | $15.03 | $14.88 | $14.44 | +518.55% |
| April, 2029 | $13.40 | $13.43 | $14.50 | +451.24% |
| May, 2029 | $10.64 | $10.67 | $11.14 | +337.75% |
| June, 2029 | $8.8471 | $8.8799 | $10.13 | +264.08% |
| July, 2029 | $15.95 | $8.3925 | $15.56 | +556.36% |
| August, 2029 | $14.33 | $14.37 | $15.53 | +489.56% |
| September, 2029 | $11.76 | $11.84 | $11.97 | +383.84% |
| October, 2029 | $9.4968 | $9.5296 | $11.22 | +290.82% |
| November, 2029 | $17.04 | $9.011 | $16.68 | +601.11% |
| December, 2029 | $15.81 | $15.83 | $16.55 | +550.66% |
Psyence Biomedical Ltd Stock (PBM) Price Forecast for 2030
Psyence Biomedical Ltd Stock (PBM) is expected to reach an average price of $14.83 in 2030, with a high forecast of $20.03 and a low forecast of $9.6295. This signifies an +510.38% surge from the last price of $2.43.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $12.56 | $12.64 | $15.23 | +417.02% |
| February, 2030 | $10.72 | $10.91 | $11.99 | +341.09% |
| March, 2030 | $18.36 | $9.6295 | $17.80 | +655.44% |
| April, 2030 | $17.34 | $17.37 | $17.62 | +613.65% |
| May, 2030 | $13.97 | $14.01 | $16.71 | +474.99% |
| June, 2030 | $12.14 | $12.19 | $13.27 | +399.70% |
| July, 2030 | $19.48 | $10.25 | $18.92 | +701.48% |
| August, 2030 | $18.34 | $18.37 | $18.71 | +654.55% |
| September, 2030 | $15.21 | $15.54 | $17.68 | +526.08% |
| October, 2030 | $12.85 | $12.90 | $14.49 | +429.01% |
| November, 2030 | $20.65 | $10.87 | $19.07 | +749.79% |
| December, 2030 | $19.83 | $19.87 | $20.03 | +716.03% |
1.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):